Related Experiment Video
Updated: Feb 23, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
AGO2 involves the malignant phenotypes and FAK/PI3K/AKT signaling pathway in hypopharyngeal-derived FaDu cells
Yanhui Zhang1, Baoxin Wang2, Xinwei Chen2
1Department of Otolaryngology Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
Argonaute 2 (AGO2) protein is usually overexpressed in various head and neck squamous cell carcinoma. However, the precise molecular mechanisms of AGO2 in hypopharyngeal cancer have not yet been clearly understood. Here we found the AGO2 expression in hypopharyngeal cancer tissues were generally higher comparing with that of the corresponding adjacent noncancerous epithelium tissues, and these were associated with the more aggressive clinicopathologic features and the poor clinical outcomes. Stable knockdown of AGO2 protein retarded cell proliferation, migration, invasion, arrested cell cycle and induced apoptosis. Meanwhile the knockdown also inhibited the FAK/PI3K/AKT signaling pathway in hypopharyngeal-derived FaDu cells. These findings suggested that AGO2 gene might act as an oncogene which contributed to the tumorigenesis and progression, and has potential values for molecular diagnosis, clinical therapies and prognosis evaluation in hypopharyngeal cancer.
Insights
Argonaute 2 (AGO2) is overexpressed in hypopharyngeal cancer, promoting tumor growth and progression. Reducing AGO2 hinders cancer cell proliferation and migration, suggesting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Argonaute 2 (AGO2) protein overexpression is observed in head and neck squamous cell carcinoma.
- The specific role of AGO2 in hypopharyngeal cancer progression remains unclear.
Purpose of the Study:
- To investigate the expression and function of AGO2 in hypopharyngeal cancer.
- To elucidate the molecular mechanisms underlying AGO2's role in hypopharyngeal cancer tumorigenesis.
Main Methods:
- Quantitative analysis of AGO2 expression in hypopharyngeal cancer tissues versus adjacent noncancerous tissues.
- Functional studies involving stable knockdown of AGO2 in hypopharyngeal cancer cell lines (FaDu).
- Assessment of cell proliferation, migration, invasion, cell cycle, and apoptosis following AGO2 knockdown.
- Analysis of the FAK/PI3K/AKT signaling pathway.
Main Results:
- AGO2 expression is significantly higher in hypopharyngeal cancer tissues compared to normal tissues.
- Elevated AGO2 levels correlate with aggressive clinicopathologic features and poor patient outcomes.
- Stable knockdown of AGO2 suppressed cell proliferation, migration, and invasion.
- AGO2 knockdown induced cell cycle arrest and apoptosis.
- Inhibition of the FAK/PI3K/AKT signaling pathway was observed after AGO2 knockdown.
Conclusions:
- AGO2 acts as an oncogene in hypopharyngeal cancer, driving tumorigenesis and progression.
- AGO2 holds potential value for molecular diagnosis, targeted therapy, and prognosis evaluation in hypopharyngeal cancer.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Affects Focal Adhesions
Some...

